A Phase III placebo-controlled trial of oral pilocarpine in patients undergoing radiotherapy for head-and-neck cancer

This publication has 16 references indexed in Scilit:

• The benefits and pitfalls of ipsilateral radiotherapy in carcinoma of the tonsillar region
  International Journal of Radiation Oncology*Biology*Physics, 2001
• Partial irradiation of the parotid gland
  Seminars in Radiation Oncology, 2001
• A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results
  International Journal of Radiation Oncology*Biology*Physics, 2001
• Post-radiation severe xerostomia relieved by pilocarpine: a prospective French cooperative study
  Radiotherapy and Oncology, 2000
• Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer
  International Journal of Radiation Oncology*Biology*Physics, 1999
• Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue
  Head & Neck, 1997
• Concomitant pilocarpine during head and neck irradiation is associated with decreased posttreatment xerostomia
  International Journal of Radiation Oncology*Biology*Physics, 1997
• Oral pilocarpine for radiation-induced xerostomia: Integrated efficacy and safety results from two prospective randomized clinical trials
  International Journal of Radiation Oncology*Biology*Physics, 1995
• Oral Pilocarpine for Post-Irradiation Xerostomia in Patients with Head and Neck Cancer
  New England Journal of Medicine, 1993
• Some factors influencing salivary function when treating with radiotherapy
  International Journal of Radiation Oncology*Biology*Physics, 1981